We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Glaxosmithkline Share News (GSK)

Glaxosmithkline Information

Buy GSK Shares
Add GSK to Watchlist
Add GSK to Alert

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange

Share Price is delayed by 15 minutes

Share Price: 1,599.00

Bid: 1,599.50

Ask: 1,600.00

Change: 15.50 (0.98%)

Spread: 0.50 (0.031%)

Open: 1,579.50

High: 1,600.00

Low: 1,575.00

Prev. Close: 1,583.50

GSK Live Price

Last checked at -

15 Apr 2014 07:22

Tuesday tips round-up: RWS Holdings, GlaxoSmithKline

As Chinese companies increasingly look to rigorously protect their intellectual property claims in the western world companies such as RWS Holdings will benefit. The firm obtains 70 per cent of its sales from translation services for corporates that allow them to protect their copyrights across a ra

15 Apr 2014 04:01

U.S. healthcare usage and spending resumes rise in 2013 -report

By Bill Berkrot April 15 (Reuters) - Americans used more health services and spent more on prescription drugs in 2013, reversing a recent trend, though greater use of cheaper generic drugs helped control spending, according to a report issued on Tuesday by a leading healthcare information c

14 Apr 2014 15:51

DIRECTOR DEALINGS: Glaxo Senior Executive Acquires ADSs

LONDON (Alliance News) - GlaxoSmithKline PLC Monday said Moncef Slaoui, a divisional chairman, and connected person K Slaoui, bought 5 American Depositary Shares under the GSK 401K plan at a price of USD51.76 per ADS. Glaxo shares were trading at USD51.89, up 0.2%, Monday. By Arvind B

14 Apr 2014 13:37

GSK rocked by bribery claims in Poland

GlaxoSmithKline (GSK) is facing a criminal investigation in Poland over claims it bribed doctors to promote its lung drug Seretide. 13 people have been charged in connection with the probe launched by Polish prosecutors, according to Poland's Central Anti-Corruption Bureau (CBA) on Monday. The dr

14 Apr 2014 11:54

REPEAT: Glaxo Says It's Cooperating With Polish Authorities On Bribery Claims

LONDON (Alliance News) - GlaxoSmithKline PLC said Monday that it was continuing to investigate allegations of bribery in its Polish operations and was co-operating fully with Poland's Central Anti-Corruption Office, after the BBC Panorama programme reported that eleven doctors and one of the comp

14 Apr 2014 11:53

Glaxo Says It Is Cooperating With Polish Authorities On Bribery Claims

LONDON (Alliance News) - GlaxoSmithKline PLC said Monday that it was continuing to investigate allegations of bribery in its Polish operations and was co-operating fully with Poland's Central Anti-Corruption Office, after the BBC Panorama programme reported that eleven doctors and one of the comp

14 Apr 2014 11:44

TOP NEWS: Aviva Sells 47% Stake In South Korean Business

LONDON (Alliance News) - The following is a summary of top news stories Monday.
----------
COMPANIES
----------
Aviva said it has agreed to sell its 47% stake in South Korean business Woori Aviva Life Insurance to NongHyup Financial Group, as the insurer co

14 Apr 2014 11:40

UK MIDDAY BRIEFING: Aviva Sells Stake In South Korean Venture

LONDON (Alliance News) - Aviva has Monday agreed to sell its 47% stake in its South Korean joint venture Woori Aviva Life Insurance to NongHyup Financial Group, as it continues to contract in the region and focus on markets where it can make the best returns on capital.

14 Apr 2014 09:10

UK BROKER RATINGS: UBS Cuts Ashmore Rating, Raises Schroders Price Target

LONDON (Alliance News) - The following UK shares received analyst recommendations Monday morning: ---------- FTSE 100 ---------- UBS REMOVED SCHRODERS FROM LEAST PREFERRED LIST ---------- UBS RAISES SCHRODERS PRICE TARGET TO 2700 (2650) PENCE - 'NEUTRAL'

14 Apr 2014 08:59

UPDATE 1-GSK faces criminal bribery investigation in Poland

* Allegations follow corruption accusations in China, Iraq * GSK says one employee disciplined for improper activity * Alleged misconduct relates to promotion of lung drug (Adds GSK and CBA statements, analyst comment, more on other bribery cases) By Ben Hirschler and Adrian K

14 Apr 2014 07:15

UK MORNING BRIEFING: Glencore Sells Interest In Peru Copper Project

LONDON (Alliance News) - Glencore Xstrata said Monday it has agreed to sell its interest in the Las Bambas copper project in Peru to a Chinese consortium including MMG, Guoxin International Investment Corp and CITIC Metal Co for USD5.85 billion in cash. The deal is part of an agreement to w

14 Apr 2014 06:39

MARKET COMMENT: UK Stocks Seen Lower On US Sell-Off, Ukraine

LONDON (Alliance News) - UK stocks are set to open firmly lower Monday, following another sharp sell-off on Wall Street on Friday and a weak Asian session overnight, and as increasing tensions in Ukraine are also likely to hurt investor sentiment. Wall Street continued its recent down trend

14 Apr 2014 05:24

PRESS: GSK Faces Bribery Probe In Poland - The BBC

LONDON (Alliance News) - UK-based drugmaker GlaxoSmithKline PLC is facing a criminal probe in Poland for allegedly paying bribes to doctors to promote its asthma drug Seretide, BBC Panorama reported on Sunday. According to the report, eleven doctors and one of Glaxo's regional managers have

13 Apr 2014 23:50

GSK faces bribery investigation in Poland -BBC

April 14 (Reuters) - GlaxoSmithKline Plc is facing a criminal investigation in Poland for allegedly bribing doctors to promote its asthma drug Seretide, BBC Panorama reported on Sunday. The BBC reported that 11 doctors and a GSK regional manager have been charged over alleged corruption bet

11 Apr 2014 15:22

DIRECTOR DEALINGS: GlaxoSmithKline Executive Directors, Managers Acquire Shares

LONDON (Alliance News) - GlaxoSmithKline PLC Friday said that the following executive directors and managers acquired shares at a price of 1585.037 pence per share on Thursday, via a dividend reinvestment.